What ethical missions can appropriately intersect with corporate profits in the context of mass tort settlements that call for continuing sales of products that involve controversies of some kind? When settlements call for continuing sales of controversial products, how should societies think about those questions? Issues of this sort are on more and more radar

Corporate officers and directors need to confront the serious risks they and their companies face in the current environment. Who says so? The famous Marty Lipton of Wachtell Lipton. See this September 19, 2019 post at Blue Sky Blog.

As Purdue seeks refuge in chapter 11, a conservative economist articulates a point I’ve also been discussing in various contexts: prepare for material reductions in or a complete end to “respect” for corporate veils. In a September 19, 2019 blog post, Mr. Cowen framed the topic around social media, famous corporate leaders and societal

Back in the early 2000s, the Fifth District appellate court in Illinois was composed of 6 Democratic judges and 1 Republican. That appellate district sits above Madison and St. Clair Counties, which were then and still are famous venues for mass tort claiming.

Today, things are very different.  Now, the count is six Republican judges

Interesting times became even more interesting when the Financial Times published an August 21, 2019 article asserting that a sex tape took on a role in Burford Capital pursuing litigation. According to the article:

“A senior executive at Burford Capital has been accused of unlawfully trading confidential documents for a sex tape in a $91m

Usually, the Institute for Legal Reform (ILR) subpart of the U.S. Chamber of Commerce attacks class action securities suits as bad things, as illustrated by this February 25, 2019 article. And, litigation funders such as Burford Capital extol the value of litigation.

Ironically, the ILT is now regularly pushing out news that rather breezily

Avoiding liability for fraudulent conveyances may have just become tougher. Why? Because this week, Kirkland & Ellis explicitly announced it is now seeking out plaintiff’s side contingent fee commercial cases, such as fraudulent conveyance cases. According to the firm’s press release, this move is motivated in part by its massive win in the chapter 11

A July 5, 2019 book review by Tyler Cowen at Marginal Revolution describes in a glowing terms a book that sounds interesting with respect to opioid issues. Among other things, the review states the following:

“The slightly misleading subtitle is How Rogue Chemists are Creating the Deadliest Wave of the Opioid Epidemic. Why misleading?